Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Laparoscopic and Endoscopic Collaborative Surgery (LECS): Minimal invasive surgery in collaboration between endoscopy and laparoscopic surgery, to locally remove the tumor
Study summary
The standard treatment for advanced gastric cancer without metastases is gastrectomy, where the whole stomach or a large proportion is removed surgically together with regional lymph nodes. Some patients cannot tolerate this invasive procedure because of old age or comorbidities. A tumor left in place can cause local symptoms such as bleeding or outlet obstruction. In this study, the investigators want to test the safety and feasibility of Laparoscopic and Endoscopic Collaborative Surgery (LECS) as a less invasive treatment option to locally remove gastric tumors without requiring extensive surgery in these frail patients. LECS is a minimally invasive surgical technique where the tumor margin is first marked from the inside with a gastroscope, followed by surgical removal of the lesion under endoscopic guidance.
Eligibility
Primary outcome measure(s)
- Severe complication — Through study completion, an average of 2 years
Clavien Dindo complication grade \>/= III
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Karolinska University Hospital | Stockholm | Sweden | Recruiting |
More Region Stockholm trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06105515 on ClinicalTrials.gov ↗ ← All trials in Sweden